Literature DB >> 15098649

A case report of occupational asthma due to gluteraldehyde exposure.

T H Ong1, K L Tan, H S Lee, P Eng.   

Abstract

INTRODUCTION: We report the first case of occupational asthma due to gluteraldehyde exposure in Singapore and also describe the use of a specific inhalational challenge (SIC) test in confirming the diagnosis. CLINICAL PICTURE: A 32-year-old laboratory technician presented with adult-onset asthma 2 years after daily exposure to gluteraldehyde which was used to sterilise the mouthpieces used for lung function testing. SIC testing showed a 25% drop in FEV1 after exposure to gluteraldehyde but not after exposure to a control, thus confirming the diagnosis. TREATMENT: Alternative arrangements were made for sterilisation of the mouthpieces so that gluteraldehyde could be removed from the workplace. There was a marked improvement in her asthmatic control thereafter.
CONCLUSIONS: This case illustrates the use of a SIC test in the diagnosis of occupational asthma. Gluteraldehyde is a known cause of occupational asthma and should be kept in mind when evaluating asthmatic patients in at-risk occupations. Effective ventilation and proper storage should be ensured to minimise exposure to gluteraldehyde where its use is necessary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098649

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  3 in total

1.  Suicidal attempt by disinfectant solution ingestion in case of opioid dependence.

Authors:  Kiana Koulaei Nejad; Mahboobeh Ghasemzadeh Rahbardar
Journal:  Clin Case Rep       Date:  2022-05-27

2.  Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach.

Authors:  Xaver Baur; Prudence Bakehe; Henning Vellguth
Journal:  J Occup Med Toxicol       Date:  2012-09-26       Impact factor: 2.646

3.  Exposure of health workers in primary health care to glutaraldehyde.

Authors:  M Angel González Jara; Alfonso Mora Hidalgo; J Carlos Avalos Gulin; Marcos López Albiach; Laura Muñoz Ortiz; Pere Torán Monserrat; Xavier Esteva Ollé
Journal:  J Occup Med Toxicol       Date:  2013-11-01       Impact factor: 2.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.